throbber
United States Patent
`Bowser et al.
`
`[19]
`
`[54] PYRITHIONE CONTAINING HAIR
`TREATMENT COMPOSITION
`
`[75]
`
`Inventors: Paul Anthony Bowser. Near Bideford;
`Jonathan David Hague. Wirral;
`Andrew Malcolm Murray. Parkgate.
`all of United Kingdom; Ruby Loo Bik
`Tan-Walker. Chester. Great Britain
`
`[73] Assignee: Chesebrough-Pond's USA Co.,
`Division of Conopco, Inc., Greenwich.
`Conn.
`
`[21] Appl. No.: 677,259
`
`[22]
`
`Filed:
`
`Jul. 9, 19%
`
`[30]
`
`Foreign Application Priority Data
`
`[EP]
`
`European Pat Off ............... 95304935
`
`Jul. 14, 1995
`Int. CL 6
`........................... A61K 7/fY75; AOlN 25/04
`[51]
`[521 u.s. c1 ...................................... 424no.t3; 424n0.17;
`424/DIG. 4; 514/852; 510/121; 510/123
`[58] Fidd of Search ................................ 424nO.l. 70.12.
`424n0.27, 70.28. DIG. 4. 70.17, 70.13;
`514/852; 510/121. 123, 124. 122
`
`[56]
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`
`I IIIII
`
`I~ 0111111111~ 11111111~1 ~0111111 ~~~I IIIII~ Ill
`5,723,112
`Mar. 3, 1998
`
`US005723112A
`[111 Patent Number:
`[451 Date of Patent:
`
`5,624,666
`
`4/1997 Coffindaffer et al ..
`
`FOREIGN PATENT DOCUMENTS
`
`0 093 601
`0 136 914
`0 173 259
`0 530 974
`05/194157
`wo 95/02389
`wo 95/22311
`
`ll/1983
`4/1985
`3/1986
`3/1993
`8/1993
`1/1995
`8/1995
`
`European Pat. Off ..
`European Pat. Off ..
`European Pat. Off ..
`European Pat. Off ..
`Japan.
`WlPO.
`WlPO.
`
`Primary Examiner-Edward J. Wehman
`Attorney, Agent, or Firm-Milton L. Honig
`
`[57]
`
`ABSTRACT
`
`The invention provides an antimicrobial hair treatment com(cid:173)
`position for topical application to human hair in the treat(cid:173)
`ment of, for example, dandruff, including:
`(a) at least one surfactant;
`(b) fine particles of an insoluble particulate metal
`pyrithione, in which at least about 90% by weight of the
`particles have a size of 5 microns or less; and
`(c) a polymeric, water-soluble cationic deposition aid for
`the fine particles.
`
`The compositions have good mechanical stability. optical
`properties and anti-dandruff ability.
`
`3,580,853
`
`5/1971 Paman, Jr ............................... 252/152
`
`8 Claims, No Drawings
`
`1
`
`

`
`5,723,112
`
`1
`PYRITHIONE CONfAINING HAIR
`TREATMENT COMPOSITION
`
`FIELD OF THE INVENTION
`
`This invention relates to antimicrobial hair treatment
`compositions for topical application to human hair for the
`treatment of. for example. dandruff. In particular. the inven(cid:173)
`tion relates to an aqueous hair treatment composition com(cid:173)
`prising a surfactant. water-insoluble antimicrobial particles
`having a specific particle size distribution and a cationic
`polymer which serves to enhance the deposition and reten(cid:173)
`tion of the particles on the hair and/or the scalp from the
`composition.
`
`BACKGROUND AND PRIOR ARf
`
`2
`acceptable products. There may also be sensory negatives to
`the user due to sedimentation of the agglomerates onto the
`hair in large sticky lumps. Consequently. deposition can be
`uneven and bioavailability of the active substance to the hair
`5 can be reduced. leading to loss of anti-dandruff benefit.
`Detergent compositions. for example shampoos, compris(cid:173)
`ing an anionic surfactant. water-insoluble particles and a
`cationic polymer have been described in U.S. Pat. No.
`3.580.853 (Parran). In the detergent compositions described
`10 in that patent the cationic polymers are water-soluble cat(cid:173)
`ionic nitrogen-containing polymers. in particular quaternary
`nitrogen substituted cellulose ether derivatives. It appears
`that the deposition enhancement of the water-insoluble
`particles derives from the presence of a complex between
`15 the anionic surfactant and the cationic polymer which is
`formed upon dilution of the detergent composition. Washing
`compositions comprising an anionic surfactant. a water(cid:173)
`insoluble particulate substance and a water-soluble cationic
`polymer which is a non-cellulose cationic polymer are
`20 described in EP 93 601.
`Neither U.S. Pat. No. 3,580.853 or EP 93 601 contain any
`specific teachings on the nature or particle size of the
`particulate substance concerned-this may be an antimicro(cid:173)
`bial such as ZnPfO and can have a particle diameter ranging
`anywhere from about 0.2 up to about 50 microns.
`It has now been found that antimicrobial hair treatment
`compositions which have good mechanical stability, and
`excellent anti-dandruff ability can be obtained by utilising
`fine particles of insoluble particulate metal pyrithione in
`combination with a deposition aid.
`
`Insoluble particulate metal pyrithiones are acknowledged
`as antimicrobial agents which can be incorporated into
`antimicrobial compositions. such as antidandruff hair sham(cid:173)
`poos and conditioners. The zinc salt (hereinafter referred to
`as ZnPTO) is widely used in this context. Generally. dis(cid:173)
`persed particles of the ZnPfO are suspended in the
`composition, which is then applied to the hair to deposit the
`ZnPTO on the hair and scalp.
`A problem encountered with such compositions is that it 25
`is difficult to obtain a stable dispersion containing ZnPfO.
`since its density can lead to separation during storage. Steps
`taken to prevent separation of the ZnPfO particles have
`hitherto included restriction of the formulational base to
`highly viscous emulsions or gels. e.g .. by incorporation of 30
`thickeners or bulking agents. such as clays or pearlescers. to
`give structural viscosity to the system and prevent ZnPfO
`settlement. Such an approach is frequently impractical for
`shampoo compositions. and can give cloudy, aesthetically-
`inferior products.
`EP-A-0 173 259 describes how this stability problem is
`particularly acute in the case of fine particulate ZnPfO.
`which is said to be very sensitive to conditions of liquid
`media for dispersion. and apt to coagulate in the presence of
`··-"
`d
`.
`. 40
`electrolytes such as salts. shampoo sw.actants an catiomc
`polymers. The reference discloses stabilisation of fine par(cid:173)
`ticulate ZnPfO in water by means of a specific dispersant.
`which may include a partly quaternised hydroxyalkylcellu(cid:173)
`lose derivative. or a particular type of copolymeric quater-
`nised cationic polymer blended with at least one inorganic
`salt. Only suspension stability is discussed; the reference
`does not address the issue of effective deposition of the
`ZnPTO active agent onto the hair during use.
`By the very nature of the form in which particles of 50
`ZnPTO are incorporated into hair treatment compositions.
`the anti-dandruff benefits attainable are frequently limited.
`owing to a poor level of deposition of the particles on the
`intended site, e.g., the hair and/or the scalp. meaning that the
`majority of the particles remain suspended in the composi- 55
`tion and are washed away during rinsing of the composition
`from the hair.
`EP-A-136914 describes an antidandruff hair care compo(cid:173)
`sition containing ZnPfO which gives enhanced ZnPfO
`deposition on the scalp. This is said to be due firstly to the
`larger particle size of the agglomerates used, at least 20% of
`which have a size of at least 5 microns, and, secondly. to the
`absence. in the composition. of "deposition interfering poly(cid:173)
`meric and clay type suspending agents".
`The problems encountered with this approach are.
`however. that utilisation of large agglomerates of ZnPfO
`can give rise to difficulties in formulating aesthetically
`
`35
`
`45
`
`SuMMARY OF THE INVENTION
`Accordingly. in one aspect the present invention provides
`an antimicrobial hair treatment composition comprising:
`(a) at least one surfactant;
`(b) fine particles of an insoluble particulate metal
`pyrithione. in which at least about 90% by weight of the
`particles have a size of 5 microns or less; and
`(c) a polymeric water-soluble cationic deposition aid for
`the fine particles.
`
`DEfAll..ED DESCRIPfiON AND PREFERRED
`EMBODIMENTS
`The insoluble particulate metal pyrithione may be repre(cid:173)
`sented by the following general formula:
`
`M n N
`
`S
`
`~ 0
`
`in which M is a polyvalent metal ion and n corresponds to
`the valency of M.
`Preferred examples of M include magnesium. barium.
`strontium. zinc. cadmium. tin and zirconium. Especially
`60 preferred is zinc.
`The fine particles of metal pyrithione have a size distri(cid:173)
`bution in which at least about 90% of the particles have a
`size of 5 microns or less. Preferably. the size distribution is
`such that at least about 90% of the particles have a size of
`65 1 micron or less. It is thought that this small size enables the
`antimicrobial particles to be delivered down to the hair
`follicle, leading to a better efficacy.
`
`2
`
`

`
`5,723,112
`
`3
`Various methods for producing fine particles of metal
`pyrithlone are described, for example, in EP-A-0 173 259.
`The amount of metal pyrithione incorporated into the
`compositions of the invention may depend on the type of
`composition and the exact nature of the material used. A 5
`preferred amount of metal pyrithione is from about 0.001 to
`about 5% by weight of the total composition, more prefer(cid:173)
`ably from about 0.1 to about 3% by weight.
`The composition according to the invention comprises at
`least one surfactant, preferably chosen from anionic. 10
`cationic. nonionic, amphoteric and zwitterionic surfactants.
`and mixtures thereof.
`A particularly preferred hair treatment composition in
`accordance with the invention is a shampoo composition in
`which at least one surfactant provides a deterging benefit. 15
`The deterging surfactant is preferably selected from anionic.
`nonionic. amphoteric and zwitterionic surfactants, and mix(cid:173)
`tures thereof.
`Suitable anionic surfactants include the alkyl sulphates.
`alkyl ether sulphates. alkaryl sulphonates, alkanoyl 20
`isethionates. alkyl succinates, alkyl sulphosuccinates.
`N-alkoyl sarcosinates. alkyl phosphates. alkyl ether
`phosphates, alkyl ether carboxylates. and alpha-olefin
`sulphonates, especially their sodium. magnesium ammo(cid:173)
`nium and mono-. eli- and triethanolamine salts. The alkyl and 25
`acyl groups generally contain from 8 to 18 carbon atoms and
`may be unsaturated. The alkyl ether sulphates. alkyl ether
`phosphates and alkyl ether carboxylates may contain from
`one to 10 ethylene oxide or propylene oxide units per
`molecule. and preferably contain 2 to 3 ethylene oxide units 30
`per molecule.
`Examples of suitable anionic surfactants include sodium
`oleyl succinate. ammonium lauryl sulphosuccinate, ammo(cid:173)
`nium lauryl sulphate, sodium dodecylbenzene sulphonate.
`triethanolamine dodecylbenzene sulphonate. sodium cocoyl 35
`isethlonate. sodium lauroyl isethionate and sodium N-lauryl
`sarcosinate. The most preferred anionic surfactants are
`sodium lauryl sulphate, triethanolamine lauryl sulphate.
`triethanolamine monolauryl phosphate. sodium lauryl ether
`sulphate lEO. 2EO and 3EO. ammonium lauryl sulphate 40
`and ammonium lauryl ether sulphate lEO, 2EO and 3EO.
`Nonionic surfactants suitable for use in compositions of
`the invention may include condensation products of ali(cid:173)
`phatic (C8-C 18) primary or secondary linear or branched
`chain alcohols or phenols with alkylene oxides. usually 45
`ethylene oxide and generally having from 6 to 30 ethylene
`oxide groups. Other suitable nonionics include mono- or
`di-alkyl alkanolamides. Example include coco mono- or
`diethanolarnide and coco mono-isopropanolarnide.
`Amphoteric and zwitterionic surfactants suitable for use so
`in compositions of the invention may include alkyl amine
`oxides. alkyl betaines, alkyl arnidopropyl betaines. alkyl
`sulphobetaines (sultaines). alkyl glycinates, alkyl
`carboxyglycinates. alkyl amphopropionates. alkylam(cid:173)
`phoglycinates alkyl arnidopropyl hydroxysultaines. acyl tau- 55
`rates and acyl glutamates. wherein the alkyl and acyl groups
`have from 8 to 19 carbon atoms. Examples include lauryl
`amine oxide. cocodimethyl sulphopropyl betaine and pref(cid:173)
`erably lauryl betaine. cocarnidopropyl betaine and sodium
`cocamphopropionate.
`The surfactants are present in shampoo compositions of
`the invention in an amount of from 0.1 to 50% by weight.
`preferably from 0.5 to 30% by weight.
`Hair treatment compositions in accordance with the
`invention may also take the form of hair conditioning 65
`compositions. which preferably comprise one or more cat(cid:173)
`ionic surfactants. The use of cationic surfactants is espe-
`
`4
`dally preferred, because these ingredients are capable of
`providing conditioning benefits to hair.
`Examples of cationic surfactants include:
`quaternary ammonium hydroxides, e.g .. tetramethylam(cid:173)
`monium hydroxide. alkyltrirnethylammonium hydroxides
`wherein the alkyl group has from about 8 to 22 carbon
`atoms, for example octyltrimethylammonium hydroxide,
`dodecyltrimethyammonium hydroxide. hexadecyltrimethy(cid:173)
`lammonium hydroxide. cetyltrimethylammonium
`hydroxide, octyldimethylbenzylammonium hydroxide.
`decyldimethylbenzy1ammonium hydroxide. stearyldi(cid:173)
`methylbenzylammonium hydroxide, didodecyldimethylam(cid:173)
`monium hydroxide, dioctadecyldimethylammon.ium
`hydroxide, tallow trimethylammonium hydroxide, cocotri-
`methylammonium hydroxide. and the corresponding salts
`thereof. e.g .. chlorides
`Cetylpyridinium hydroxide or salts thereof. e.g .. chloride
`Quaternium -5
`Quaternium -31
`Quaternium -18
`and mixtures thereof.
`In hair conditioning compositions according to the
`invention. the level of cationic surfactant is preferably from
`0.01 to 10%, more preferably 0.05 to 5%, most preferably
`0.1 to 2% by weight of the composition.
`Hair treatment compositions of the invention may also
`contain one or more conditioning agents. as are well known
`in the art. The conditioning agents may include silicones.
`protein hydrolyzates. quaternised protein hydrolysates and
`other materials which are known in the art as having
`desirable hair conditioning properties.
`Silicones are the most preferred conditioning agents.
`Suitable silicones include volatile and non-volatile
`silicones. such as for example polyalkylsiloxanes. polyalky(cid:173)
`laryl siloxanes, siloxane gums and resins. cyclomethicones.
`arninofunctional silicones. quaternary silicones and mix-
`tures thereof. Silicone oil is a particularly preferred condi(cid:173)
`tioning agent for hair. The silicone may be in the form of a
`low viscosity oil which may contain a high viscosity oil or
`gum in solution. Alternatively. the high viscosity material
`may be in the form of an emulsion in water. The emulsion
`may be of high viscosity oil or of a solution of gum in a
`lower viscosity oil. The particle size of the oil phase may be
`anywhere in the range from 30 nanometers to up to 20
`microns average size.
`The silicone oil may suitably be a polydimethylsiloxane
`with an average particle size of less than 20 microns and
`preferably less than 2 microns. Small particle size enables a
`more uniform distribution of silicone conditioning agent for
`the same concentration of silicone in the composition.
`Advantageously. a silicone with a viscosity in the range
`1-20 million est is used. The silicone is preferably emulsion(cid:173)
`polymerised. since this enables silicones of very high vis(cid:173)
`cosity to be more easily processed. The silicone can be
`eros s-linked.
`Suitable protein hydrolysates include lauryl dimonium
`hydroxy propylarnino hydrolysed animal protein. available
`commercially under the trade name LAMEQUPJ L. and
`hydrolysed keratin containing sulphur-bearing amino acids.
`60 available commercially under the trade name CROQUPJ
`WKP.
`In accordance with the invention. the hair treatment
`composition contains a polymeric water-soluble cationic
`deposition aid for the fine particles. By "deposition aid" is
`meant an agent which enhances deposition of the fine
`particles of metal pyrithione on the intended site, i.e .. the
`hair and/or the scalp.
`
`3
`
`

`
`5
`
`5
`The deposition aid will generally be present at levels of
`from 0.01 to 5%, preferably from about 0.5 to 1%, more
`preferably from about 0.08% to about 0.5% by weight.
`Preferably the cationic charge density of the deposition
`aid, which is defined as the reciprocal of the molecular
`weight of a monomeric unit of the polymer containing 1
`charge, is at least 0.1 meq/g, preferably above 0.8 or higher.
`The cationic charge density should not exceed 4 meqlg. it is
`preferably less than 3 and more preferably less than 2 meqlg.
`The charge density can be measured using conductimetric
`analysis and should be within the above limits at the desired
`pH of use, which will in general be from about 3 to 9 and
`preferably between 4 and 8.
`Preferred deposition aids are cationic derivatives of guar
`gum and cationic polyacrylamides.
`Suitable cationic derivatives of guar gum are JAGUAR
`C13S. which has a low degree of substitution of the cationic
`groups and high viscosity. JAGUAR C15. having a moder-
`ate degree of substitution and a low viscosity, JAGUAR C17
`(high degree of substitution, high viscosity). JAGUAR C16,
`which is a hydroxypropylated cationic guar derivative con(cid:173)
`taining a low level of substituent groups as well as cationic
`quaternary ammonium groups, and JAGUAR 162 which is
`a high transparency, medium viscosity guar having a low
`degree of substitution.
`A particularly preferred deposition aid is Jaguar C13S
`with a cationic charge density of 0.8 meqlg. Other particu(cid:173)
`larly suitable materials include Jaguar C15, Jaguar C17 and
`Jaguar C16 and Jaguar C162.
`Suitable cationic polyacrylamides are described in WO
`95/22311.
`The composition may further comprise from 0.1 to 5% of
`a suspending agent. Examples are polyacrylic acids. cross
`linked polymers of acrylic acid. copolymers of acrylic acid
`with a hydrophobic monomer, copolymers of carboxylic
`acid-containing monomers and acrylic esters. cross-linked 35
`copolymers of acrylic acid and acrylate esters, het(cid:173)
`eropolysaccharide gums and crystalline long chain acyl
`derivatives. The long chain acyl derivative is desirably
`selected from ethylene glycol stearates, alkanolamides of
`fatty acids having from 16 to 22 carbon atoms and mixtures 40
`thereof. Polyacrylic acid is available commercially as Car(cid:173)
`bopol 420. Carbopol 488 or Carbopol 493. Polymers of
`acrylic acid cross-linked with a polyfunctional agent may
`also be used, they are available commercially as Carbopol
`910, Carbopol 934. Carbopol 940. Carbopol 941 and Car- 45
`bopol 980. An example of a suitable copolymer of a car(cid:173)
`boxylic acid containing a monomer and acrylic acid esters is
`Carbopol 1342. All Carbopol materials are available from
`Goodrich and Carbopol is a trade mark. A further suitable
`suspending agent is dihydrogenated tallow phthalic acid 50
`amide (available from Stepan Chemical Co. under the trade(cid:173)
`mark Stepan TAB-2)
`Suitable cross linked polymers of acrylic acid and acrylate
`esters are Pemulen TR1 or Pemulen TR2. A suitable het(cid:173)
`eropolysaccharide gum is xanthan gum. for example that 55
`available as Kelzan mu.
`Another ingredient that may advantageously be incorpo(cid:173)
`rated into hair treatment compositions of the invention is a
`fatty alcohol material. The use of these materials is espe(cid:173)
`cially preferred in conditioning compositions of the 60
`invention, in particular conditioning compositions which
`comprise one or more cationic surfactant materials. The
`combined use of fatty alcohol materials and cationic surfac(cid:173)
`tants in conditioning compositions is believed to be espe(cid:173)
`cially advantageous, because this leads to the formation of 65
`a lamellar phase. wherein the cationic surfactant is
`dispersed.
`
`6
`Preferred fatty alcohols comprise from 8 to 22 carbon
`atoms, more preferably 16 to20. Examples of preferred fatty
`alcohols are cetyl alcohol and stearyl alcohol. The use of
`these materials is also advantageous in that they contnbute
`to the overall conditioning properties of compositions of the
`invention.
`The level of fatty alcohol materials is conveniently from
`0.01 to 10%. preferably from 0.1 to 5% by weight of the
`composition. The weight ratio of cationic surfactant to fatty
`10 alcohol is preferably from 10:1 to 1:10. more preferably
`from 4:1 to 1:8, most preferably from 1:1 to 1:4.
`The hair treatment compositions of the invention are
`preferably aqueous based. The compositions suitably com(cid:173)
`prise water in amount of from about 20 to about 99% by
`15 weight of the total composition.
`The compositions of the invention are preferably rinse-off
`compositions. i.e., suitable for applying to the hair and/or
`scalp, left thereon for an appropriate period of time and then
`rinsed off with water. Thus, shampoos are a particularly
`20 preferred product form for compositions of the invention.
`Depending on the type of composition employed. one or
`more additional ingredients conventionally incorporated
`into hair treatment formulations may be included in the
`compositions of the invention. Such additional ingredients
`25 include opacifiers such as polyethylene glycol distearate and
`ethylene glycol stearates. polymer lattices, additional anti(cid:173)
`microbial agents. foam boosters. perfumes. colouring
`agents. preservatives, viscosity modifiers, proteins.
`polymers. buffering or pH adjusting agents. moisturising
`30 agents, herb or other plant extracts and other natural ingre(cid:173)
`dients.
`The invention is further illustrated by way of the follow(cid:173)
`ing non-limitative examples.
`
`EXAMPLES 1 & 2
`Hair shampoo compositions in accordance with the
`present invention. comprising fine particulate metal
`pyrithione and a deposition polymer were prepared. The two
`compositions had the following formulations.
`
`INGREDIENf
`
`EXAMPLE l
`
`EXAMPLE2
`
`% BYWEIGIIT
`
`Sodium Iaury! ether
`sulphate 2EO (28% active)
`Cocamidopropyl betaine
`(30% active)
`Jaguar C13S
`Zinc pyrithione, fin<> particle
`size (48% active)
`CARBOPOL 980
`Ethylene glycol monostearate
`Dimcthicone (60% aqueous
`emulsion)
`Zinc sulphate heptahydrate
`Vitamin E acetate
`Preservative, colour,
`fragrance
`Water
`
`50
`
`50
`
`6.7
`
`0.1
`2.08
`
`0.4
`3.0
`1.7
`
`0.1
`0.05
`
`6.7
`
`0.1
`2.08
`
`0.4
`3.0
`3.34
`
`0.1
`0.05
`
`q.s.
`
`to 100%
`
`Both shampoos gave excellent anti-dandruff performance
`on the hair. and were stable without visible signs of sepa(cid:173)
`ration after three months storage both at room temp·erature
`and at 45° C.
`
`EXAMPlE 3
`A series of compositions were prepared to test the level of
`deposition on skin of zinc pyrithione from formulations
`
`4
`
`

`
`5.723,112
`
`7
`according to the invention compared with control formula(cid:173)
`tions containing no deposition polymer, and to demonstrate
`the effect of reducing the particle size of the zinc pyrithione.
`
`Composition (% wt)
`
`Ingredient
`
`&xliwnlawylernerswphme
`Cocamidopropylbetaine
`Dimetbicone emmsionC' 1
`Zinc pyritbioneC2l
`Zinc pyritbioneC3l
`Carbomer
`Guar hydroxypropyl trimoniwn
`chloride
`VeegwnC4l
`
`A
`
`14
`2
`
`0.6
`
`B
`
`14
`2
`1
`
`1
`0.6
`0.1
`
`c
`
`14
`2
`
`0.6
`0.1
`
`''>x2-1766 gum, ex Dow Coming
`t2lzinc pyrithione ex Olin, 90% of particles size less than 1 micron
`C3lzinc pyrithione ex Olin, 90% of particles size less than 5 micron
`c•:>colloidal magnesium aluminium silicate, ex R. T. Vanderbilt
`
`8
`wavelength dispersive X-ray fluorescence spectrometer. The
`nett zinc counts were obtained by subtracting the counts
`obtained from blank tape strips from the gross Zinc counts.
`The results are shown below in Table 1:
`
`TABLE 1
`
`Composition
`
`Zinc deposited (Kcounts/s)
`
`A
`B
`c
`
`0.23
`0.45
`0.63
`
`5
`
`10
`
`15
`
`Comparison of the level of zinc deposition from Compo(cid:173)
`sitions A and B respectively shows a statistically significant
`difference. with a confidence level of >99%. in favour of
`composition B. containing cationic deposition polymer.
`Comparison of the level of zinc deposition from Compo(cid:173)
`sitions B and C respectively shows a statistically significant
`20 difference. with a confidence level of >99%. in favour of
`composition C, containing smaller particle size zinc
`pyrithione.
`We claim:
`1. An antimicrobial hair treatment composition compris(cid:173)
`ing:
`
`25
`
`Each of the above Compositions A to C was subjected to
`a standard deposition test on skin and the level of zinc
`pyrithione deposited in each case was measured using the
`technique of X-ray fluorescence. The methods used are
`described below:
`Panellist Selection
`Ten panellists (5 male and 5 female; age 18-60 years)
`were recruited from volunteers who did not suffer from any
`skin disorders such as psoriasis or eczema.
`Test Procedure
`On each inside forearm., six circular areas of diameter 25 30
`mm were marked using ball-point pen. Before product
`application, one of the circles on each forearm was tape(cid:173)
`stripped using J-Clear tape. Pressure was applied to the
`taped area for 30 seconds using a rubber press. This initial
`tape strip was used to determine the baseline reading.
`a) Calibration
`For the calibration test, on each of the remaining area, 20
`J.il of diluted ZnPfO Fine Particle Size grade *(ex. Olin) was
`applied and allowed to dry. The final amounts of ZnPfO
`dosed at each of the sites were 0.1,2,5 and 10 ~g/cm2 of 40
`ZnPTO. The calibration was then repeated on the other arm.
`*(Fine Particle Size grade: 90% of ZnPTO particles have
`less than 1 micron size).
`b) Composition Application
`On each of the remaining areas. each composition was
`applied as follows:
`Apolythene cylinder of inner diameter 25 mm was placed
`on the marked circle and pressed to the skin to make a seal.
`100 J.il of tenfold diluted composition (3 g composition
`diluted with 27 g distilled water) was applied to the marked
`area and agitated for 30 seconds using a glass rod. The
`composition was then rinsed with 2x5 ml of distilled water.
`directed over the application area using a syringe.
`The test compositions were applied to designated sites
`according to a balanced position allocation to minimise any
`bias. Replicates were carried out using a repeat design after
`randomising row positions.
`After 15 minutes of drying. each circle was tape-stripped
`using J-Clear tape. Pressure was applied to each taped area
`for 30 seconds using a rubber press. Zinc counts on the
`tape-strips were measured using X-ray fluoresence spectros-
`copy.
`XRF Fluorescence Spectroscopy Analysis of Zinc and Sul(cid:173)
`phur Content
`The tape strips were mounted on aluminium rings and
`measured for zinc and sulphur using a Philips PW2400
`
`(a) from 0.1 to 50% by weight of surfactant;
`(b) from 0.001 to 5% by weight of fine particles of an
`insoluble particulate metal pyrithione. in which at least
`about 90% by weight of the particles have a size of 1
`microns or less; and
`(c) from 0.01 to 5% by weight of a polymeric. water(cid:173)
`soluble cationic deposition aid for the fine particles.
`2. A composition according to claim 1 in which metal
`pyrithione is zinc pyrithione.
`3. A composition according to claim 1 in which the metal
`pyrithione is present in the composition in an amount of
`from about 0.1 to about 3% by weight.
`4. A composition according to claim 1 in which the
`deposition aid is a cationic derivative of guar gum or a
`cationic polyacrylamide.
`S. A composition according to any preceding claim. which
`is shampoo composition. in which at least one surfactant is
`selected from anionic. nonionic. amphoteric and zwitteri(cid:173)
`onic surfactaots, and mixtures thereof, in a total amount of
`from about 0.5 to 30% by weight of the composition.
`6. A composition according to claim 1. which further
`comprises a conditioning agent selected from volatile and
`non-volatile silicones.
`7. A method of treating dandruff comprising applying to
`the hair an antimicrobial composition comprising:
`(a) from 0.1 to 50% by weight of surfactant;
`(b) from 0.001 to 5% by weight of fine particles of an
`insoluble particulate metal pyrithione. in which at least
`about 90% by weight of the particles have a size of 1
`microns or less; and
`(c) from 0.01 to 5% by weight of a polymeric. water(cid:173)
`soluble cationic deposition aid for the fine particles.
`8. A composition according to claim 4 wherein the cat(cid:173)
`ionic deposition aid is guar hydroxypropyl trimonium
`chloride.
`
`* * * * *
`
`35
`
`45
`
`50
`
`55
`
`60
`
`5

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket